Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The purpose of this study was to determine the safety and efficacy of TAK-559, once daily (QD), in Type 2 Diabetes subjects.
Epistemonikos ID: 0b80538595580d2ba8a3527940abdc8425cef8b8
First added on: May 05, 2024